The method would also be more effective at stopping the disease from returning by reprogramming cancer-fighting cells, researchers said.
The technique takes white blood cells and transforms them into stem cells before being reprogrammed to fight the patient's cancer, the 'Daily Express' reported.
"This is very specific to the cancer cells themselves. This means fewer side effects and secondly, because they stay in the body, they are 'living drugs' and once present move around and stop recurrences," said lead researcher Dr Michel Sadelain, of the Memorial Sloan-Kettering Cancer Center in New York.
"It looks pretty exciting. It's effectively using the body's own immune system and harnessing its power to attack the cancer cells," Dr Emma Smith, senior science information officer at Cancer Research UK, said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
